News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immuno-Designed Molecules Signs An R&D Agreement On Anti-Cancer Vaccine With The Walter Reed Army Institute of Research


10/19/2005 5:12:06 PM

IDM (Immuno-Designed Molecules), a biopharmaceutical company specialized in immunotherapy for the treatment of cancer, announced today the signing of a research and development agreement with the Walter Reed Army Institute of Research located in Silver Spring, Maryland.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES